Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated c...

Por Shah, Parth, Glueck, Charles J., Goldenberg, Naila, Min, Sarah, Mahida, Chris, Schlam, Ilana, Rothschild, Matan, Huda, Ali, Wang, Ping
Publicado no Lipids Health Dis (2017)

Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy

Por Jarman, Michael Ian, Lee, Kevin, Kanevsky, Ariel, Min, Sarah, Schlam, Ilana, Mahida, Chris, Huda, Ali, Milgrom, Alexander, Goldenberg, Naila, Glueck, Charles J., Wang, Ping
Publicado no BMC Hematol (2017)